Pancreatic Cancer Research

ResearcherChiba Cancer CenterNo recent work listed

Osamu Shimozato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7508-5809; OpenAlex author ID A5027672648. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers

Papers 8

  1. Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer. Co-author DOI 10.1371/journal.pone.0268630↗
  2. Machine learning with imaging features to predict the expression of ITGAV, which is a poor prognostic factor derived from transcriptome analysis in pancreatic … Co-author DOI 10.3892/ijo.2022.5350↗
  3. Impact of RUNX2 gene silencing on the gemcitabine sensitivity of p53‑mutated pancreatic cancer MiaPaCa‑2 spheres. Co-author DOI 10.3892/or.2018.6344↗
  4. Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 … Co-author DOI 10.1371/journal.pone.0179884↗
  5. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death. Co-author DOI 10.1038/oncsis.2016.40↗
  6. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TA… Last author DOI 10.18632/oncotarget.12433↗
  7. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Co-author DOI 10.1038/cddis.2015.242↗
  8. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Co-author DOI 10.1038/cddiscovery.2015.10↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mizuyo Nakamura · 6 shared papers, 2015–2018 · strength 0.38
  2. Toshinori Ozaki · 6 shared papers, 2015–2018 · strength 0.38
  3. Hiroki Nagase · 4 shared papers, 2015–2022 · strength 0.35
  4. Meijie Sang · 5 shared papers, 2015–2018 · strength 0.33
  5. Yosuke Iwatate · 2 shared papers, 2022 · strength 0.25
  6. Fumitaka Ishige · 2 shared papers, 2022 · strength 0.25
  7. Naoki Kuwayama · 2 shared papers, 2022 · strength 0.25
  8. Hidehito Arimitsu · 2 shared papers, 2022 · strength 0.25
  9. Yasukuni Mori · 2 shared papers, 2022 · strength 0.25
  10. Takashi Uno · 2 shared papers, 2022 · strength 0.25
  11. Wataru Takayama · 2 shared papers, 2022 · strength 0.25
  12. Takehiro Ogata · 3 shared papers, 2016–2018 · strength 0.22
  13. Meixiang Sang · 3 shared papers, 2015–2017 · strength 0.18
  14. Hirokazu Sugimoto · 3 shared papers, 2015–2016 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.